EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    3.1.1.23 | Myocardial Infarction |
30295758 |
2-arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction. |
causal interaction
unassigned |
1
0 |
| 3.1.1.23 | Encephalomyelitis |
28751457 |
2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
| 3.1.1.23 | Neuroinflammatory Diseases |
28751457 |
2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
| 3.1.1.23 | Neoplasms |
31668797 |
?-Quinazolinonylalkyl aryl ureas as reversible inhibitors of monoacylglycerol lipase. |
therapeutic application
unassigned |
2
0 |
| 3.1.1.23 | Fatty Liver |
26491015 |
?/? Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate. |
causal interaction
unassigned |
4
0 |
| 3.1.1.23 | Obesity |
26491015 |
?/? Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate. |
causal interaction
unassigned |
4
0 |
| 3.1.1.23 | Tuberculosis |
20601476 |
A monoacylglycerol lipase from Mycobacterium smegmatis Involved in bacterial cell interaction. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
| 3.1.1.23 | Neuroinflammatory Diseases |
26694017 |
A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography. |
unassigned |
0 |
| 3.1.1.23 | Multiple Sclerosis |
25298214 |
A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis. |
therapeutic application
unassigned |
4
0 |
| 3.1.1.23 | Liver Neoplasms |
31076001 |
Aberrant lipid metabolism as a therapeutic target in liver cancer. |
unassigned |
0 |
